Predicted clinical and economic burden associated with reduction in access to acute coronary interventional care during the COVID-19 lockdown in two European countries
Authors' conclusion
The effect of a 1-month lockdown on STEMI treatment led to a reduction in survival and QALYs compared to the pre-pandemic era.
Study context
- Population
- ST-elevation myocardial infarction (STEMI) patients during the first COVID-19 lockdown in the UK and Spain
- Comparison
- STEMI during first COVID-19 lockdown vs expected pre-lockdown outcomes
- Outcome
- Long-term health outcomes (survival and QALYs) and cost of reduced STEMI treatment
Methodological detailsMarkov model, health-economic analysis
- Markov model
- Health-economic analysis
Main finding
As reported in the abstract
UK: life-years lost
1.55
UK: Quality-adjusted life-years (QALYs) lost
1.17
Spain: reduction in survival (years)
2.03
Spain: change in QALYs
−1.63
Further findings
Additional lifetime costs at population level
- UK total additional lifetime costs (annual STEMI incidence 49 332), mainly work absenteeism
- £36.6 million (€41.3 million)
- Spain additional costs
- €88.6 million
Original publication
Predicted clinical and economic burden associated with reduction in access to acute coronary interventional care during the COVID-19 lockdown in two European countries. Eur Heart J Qual Care Clin Outcomes. Published 7 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →